Sigma Metric Analysis
For over a year, we've been looking at the impact of new CLIA and EFLM goals on the assessment of biochemistry instruments. Well, the goals for hematology have changed as well. How does a Sysmex XN 350 fare when judged by the latest goals for CLIA and EFLM
What happened to laboratory quality during the pandemic? There's what we suspect, and what we can actually quantify. A laboratory in India made the ultimate assessment: they collected data on their VITROS 5600 both before and during their COVID lockdown. The results are serious. Looking through the lens of EFLM and CLIA goals, it's even more serious.
Multimode analysis isn't just for chemistry assays. It's time to look at immunoassay performance from the major diagnostic manufacturers. IA is an area where the goal differences get bigger. As EFLM gets wider and CLIA gets tighter, the impacts in IA are also important. This time we look at a Roche cobas 6000, with a evaluation of measurement uncertainty as the cherry on top.
In our multimode analysis series, we've focused on the performance of the major diagnostic manufacturers. But when EFLM gets wider and CLIA gerts tighter, other instruments are impacted, too. This time we look at a small benchtop analyzer in India, the MicroLab RX-50. While this small device succeed where the big boxes failed?
EFLM has gotten wider. CLIA has gone tighter. it's time to take another look at a major instrument system. Ricos 2014, EFLM minimum and desirable, CLIA 1992 and 2024. How does an Alinity stack up?